Beta-Defensin-2 (Human)

Beta-Defensin-2 (Human)

0.1 mg
€285,00

Sie können eine Angebotsanfrage erstellen, nachdem Sie das Produkt in den Warenkorb gelegt haben.

Zu Produktinformationen springen
Beta-Defensin-2 (Human)
  • Beta-Defensin-2 (Human)
  • Beta-Defensin-2 (Human)

Beta-Defensin-2 (Human)

Produkt-ID: 4338

Gly – Ile – Gly – Asp – Pro – Val – Thr – Cys – Leu – Lys – Ser – Gly – Ala – Ile – Cys – His – Pro – Val – Phe – Cys – Pro – Arg – Arg – Tyr – Lys – Gln – Ile – Gly – Thr – Cys – Gly – Leu – Pro – Gly – Thr – Lys – Cys – Cys – Lys – Lys – Pro

€285,00
exkl. 19% MwSt.
Beschreibung

hBD-2 | Human β-Defensin-2

M.W. 4328.2

C188H305N55O50S6

Gly – Ile – Gly – Asp – Pro – Val – Thr – Cys – Leu – Lys – Ser – Gly – Ala – Ile – Cys – His – Pro – Val – Phe – Cys – Pro – Arg – Arg – Tyr – Lys – Gln – Ile – Gly – Thr – Cys – Gly – Leu – Pro – Gly – Thr – Lys – Cys – Cys – Lys – Lys – Pro

This antimicrobial peptide Human Beta-Defensin-2 specific for Gram-Negative Bacteria and effective for Candida albicans was originally isolated from skin cells from Psoriasis-patients. The expression of hBD-2 by skin cells is a direct response to a local infection by Pseudomonas aeruginosa or other bacteria. Peptide LL-37 and hBD-2 might be able to protect the skin of patients with psoriasis and both peptides may be involved in the pathogenesis of psoriasis. Additionally beta-Defensin-2 is suspected to play a distinct role in Crohn’s disease. Beta-Defensin-2 (human) offered from PeptaNova is a chemical synthesized peptide of highest purity for medical and biological research. 4338-s (0.1 mg) Beta-Defensin-2 manufactured by Peptide Institute, Inc. is available for prompt delivery ex stock Germany.

Synthetic Product (disulfide bonds between Cys8-Cys37, Cys15-Cys30 and Cys20-Cys38)

The purity of Human Beta-Defensin-2 is guaranteed to be higher than 99% by HPLC

Referenzen:

1. T. Harder, J. Bartels, E. Christophers and J.M. Schröder, Nature, 387, 861 (1997) (Original; Human Beta-Defensin-2) 2. T. Hiratsuka, M. Nakazato, Y. Date, J. Ashitani, T. Minimatsu, N. Chino and S. Matsukura, Biochem. Biophys. Res. Commun., 249, 943 (1998) (Pharmacology of hBD-2) 3. D.M. Hoover, K.R. Rajashankar, R. Blumenthal, A. Puri, J.J. Oppenheim, O. Chertov and J. Lubkowski, J. Biol. Chem., 275, 32911 (2000) (S-S Bond) 4. T. Hiratsuka, H. Mukae, H. Iiboshi, J. Ashitani, K. Nabeshima, T. Minimatsu, N. Chino, T. Ihi, S. Kohno and M. Nakazato, Thoray, 58, 425 (2003) (Pharmacol; Activity of beta-Defensin-2 against Pseudimonas aeruginosa)

Downloads

You may also like